- Home
- OB vs AQST Comparison
OB vs AQST Comparison
Compare OB & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OB
- AQST
- Stock Information
- Founded
- OB 2006
- AQST 2004
- Country
- OB United States
- AQST United States
- Employees
- OB N/A
- AQST N/A
- Industry
- OB Industrial Machinery/Components
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- OB Industrials
- AQST Health Care
- Exchange
- OB Nasdaq
- AQST Nasdaq
- Market Cap
- OB 269.6M
- AQST 285.4M
- IPO Year
- OB 2021
- AQST 2018
- Fundamental
- Price
- OB $6.61
- AQST $3.21
- Analyst Decision
- OB Buy
- AQST Strong Buy
- Analyst Count
- OB 5
- AQST 8
- Target Price
- OB $6.66
- AQST $10.38
- AVG Volume (30 Days)
- OB 288.1K
- AQST 1.4M
- Earning Date
- OB 02-27-2025
- AQST 03-04-2025
- Dividend Yield
- OB N/A
- AQST N/A
- EPS Growth
- OB N/A
- AQST N/A
- EPS
- OB N/A
- AQST N/A
- Revenue
- OB $903,518,000.00
- AQST $58,900,000.00
- Revenue This Year
- OB $0.80
- AQST $18.44
- Revenue Next Year
- OB $8.13
- AQST N/A
- P/E Ratio
- OB N/A
- AQST N/A
- Revenue Growth
- OB N/A
- AQST 22.56
- 52 Week Low
- OB $3.42
- AQST $2.24
- 52 Week High
- OB $7.87
- AQST $6.23
- Technical
- Relative Strength Index (RSI)
- OB 50.89
- AQST 39.38
- Support Level
- OB $6.36
- AQST $3.04
- Resistance Level
- OB $6.53
- AQST $3.30
- Average True Range (ATR)
- OB 0.27
- AQST 0.20
- MACD
- OB -0.11
- AQST 0.02
- Stochastic Oscillator
- OB 48.98
- AQST 30.12
About OB Outbrain Inc.
Outbrain Inc is a platform powering the open web that matches audiences with personalized content and ads, driving quality engagement. Its platform delivers ads to end-users that appear as links to articles, products, and videos on media partners' sites. It derives revenue from advertisers through user engagement with the ads that it places on media partners' web pages and mobile applications. The company has its geographic presence in Europe, the Middle East, and Africa followed by the USA and others.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.